← Back

Wire · regulatory

Montana To Open Up Unapproved, Experimental Drugs To Consumers

Published

16 September 2026

Topic

regulatory

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at kffhealthnews.org →

◆ Verified

Fusion42 · 16 September 2026 · Fusion42 review

Montana passed a law allowing consumer access to unapproved, experimental drugs via a private board, requiring patient consent, provider recommendation, and payment, raising concerns about FDA penalties and patient safety.

This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it between 16 Sep 2026 and 18 Sep 2026.

◆ ◆ The Wire takeaway

You face a new regulatory frontier where unapproved drugs can reach consumers in Montana, challenging FDA conventions and exposing your firm to compliance risks or new market openings.

◆ Coverage

2 sources · first reported 16 Sep 2026 · latest 18 Sep 2026

◆ Related on Wire

◆ Topics

Biotechexperimental-drugsregulatory-riskpatient-accessbiotechfda